EcoDrugPlus

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSLCAG00010023893
Gene Symbol: IDH2
2 Cross references
186 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSLCAG00010005797
Gene Symbol: IDH2
1 Cross references
207 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSLCAG00010025348
Gene Symbol: KEAP1B
4 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor (A Type Iii Receptor Tyrosine Kinase)

Ensembl ID : ENSLCAG00010005596
Gene Symbol: LOC108879132
4 Cross references
195 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSLCAG00010002709
Gene Symbol: KIF5B
4 Cross references
234 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSLCAG00010003948
Gene Symbol: KIF5B
1 Cross references
236 Possible Orthologues:

Lectin, Galactoside Binding Soluble 3a

Ensembl ID : ENSLCAG00010023567
Gene Symbol: LGALS3A
1 Cross references
220 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSLCAG00010010687
Gene Symbol: LOC108892403
4 Cross references
203 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSLCAG00010016965
Gene Symbol: LOC108890837
4 Cross references
142 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSLCAG00010016963
Gene Symbol: LOC108890838
3 Cross references
157 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSLCAG00010000748
Gene Symbol: LTB4R2B
4 Cross references
167 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor

Ensembl ID : ENSLCAG00010013289
Gene Symbol: LOC108879681
4 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).